Jefferies Financial Group Inc. Acquires 11,523 Shares of Addus HomeCare Corporation $ADUS

Jefferies Financial Group Inc. bought a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 11,523 shares of the company’s stock, valued at approximately $1,274,000. Jefferies Financial Group Inc. owned about 0.06% of Addus HomeCare at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC grew its position in shares of Addus HomeCare by 110.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 189,718 shares of the company’s stock valued at $21,192,000 after purchasing an additional 99,596 shares during the last quarter. Hohimer Wealth Management LLC increased its stake in shares of Addus HomeCare by 5.4% in the third quarter. Hohimer Wealth Management LLC now owns 2,809 shares of the company’s stock worth $311,000 after purchasing an additional 143 shares during the period. Heritage Family Offices LLP bought a new position in shares of Addus HomeCare in the third quarter worth about $43,000. Bridge City Capital LLC lifted its position in shares of Addus HomeCare by 25.9% during the 3rd quarter. Bridge City Capital LLC now owns 107,577 shares of the company’s stock worth $11,892,000 after purchasing an additional 22,132 shares during the last quarter. Finally, Vise Technologies Inc. acquired a new position in shares of Addus HomeCare during the 3rd quarter worth about $422,000. 95.35% of the stock is currently owned by institutional investors.

Insider Activity

In other Addus HomeCare news, EVP David W. Tucker sold 14,850 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $124.75, for a total value of $1,852,537.50. Following the completion of the sale, the executive vice president owned 8,073 shares in the company, valued at approximately $1,007,106.75. This trade represents a 64.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R. Allison sold 98,958 shares of the firm’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $123.27, for a total value of $12,198,552.66. Following the completion of the sale, the chief executive officer owned 183,150 shares of the company’s stock, valued at $22,576,900.50. This represents a 35.08% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 141,894 shares of company stock valued at $17,536,266. Corporate insiders own 4.10% of the company’s stock.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS traded down $0.72 on Friday, hitting $123.00. 105,094 shares of the company were exchanged, compared to its average volume of 256,876. The company’s 50 day moving average price is $118.39 and its two-hundred day moving average price is $107.25. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $131.59. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.64 and a current ratio of 1.64. The firm has a market capitalization of $2.29 billion, a price-to-earnings ratio of 20.50, a PEG ratio of 1.63 and a beta of 0.75.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The business had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. During the same quarter in the prior year, the business earned $1.56 earnings per share. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. Research analysts expect that Addus HomeCare Corporation will post 6.41 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on ADUS shares. Bank of America lowered Addus HomeCare from a “buy” rating to a “neutral” rating and lowered their target price for the company from $140.00 to $125.00 in a report on Monday, September 14th. Raymond James Financial set a $137.00 price target on Addus HomeCare in a research report on Monday, September 28th. TD Cowen upped their price target on Addus HomeCare from $131.00 to $145.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. Truist Financial increased their price objective on Addus HomeCare from $135.00 to $148.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Finally, Barclays increased their price objective on Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a research report on Wednesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $136.33.

Get Our Latest Report on ADUS

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

Featured Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.